Image de couverture de livre

The integral membrane protein SMIM38 is transcriptionally activated in circulating tumor cells in human breast cancer in conjunction with two SMIM38-interacting proteins of undefined function, ETDA and ETDB.

Fuente: Zenodo

Enregistré dans:

Détails bibliographiques
Auteur principal:	Mamoor, Shahan
Format:	Recurso digital
Publié:	Zenodo 2025
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

The homeobox transcription factor TCF7 is activated in and likely required for metastasis to the lymph nodes in humans with breast cancer.
par: Mamoor, Shahan
Publié: (2025)

The homeobox transcription factor MEOX1 is activated in and likely required for metastasis to the lymph nodes in humans with breast cancer.
par: Mamoor, Shahan
Publié: (2025)

A comprehensive description of the circulating tumor cell: PTPRU.
par: Mamoor, Shahan
Publié: (2025)

A comprehensive description of the circulating tumor cell: ITGAD.
par: Mamoor, Shahan
Publié: (2025)

A comprehensive description of the circulating tumor cell: TMEM25.
par: Mamoor, Shahan
Publié: (2025)

A comprehensive description of the circulating tumor cell: EXD3.
par: Mamoor, Shahan
Publié: (2025)

A comprehensive description of the circulating tumor cell: HCAR1.
par: Mamoor, Shahan
Publié: (2025)

A comprehensive description of the circulating tumor cell: GPRC5A.
par: Mamoor, Shahan
Publié: (2025)

A comprehensive description of the circulating tumor cell: TM6SF1.
par: Mamoor, Shahan
Publié: (2025)

A comprehensive description of the circulating tumor cell: Fzd4/Fzd3.
par: Mamoor, Shahan
Publié: (2025)

Activation of ZIC family genes in CNS metastasis in humans with breast cancer.
par: Mamoor, Shahan
Publié: (2025)

The range of Xist transcriptional targets in non-small cell lung cancer: MYC.
par: Mamoor, Shahan
Publié: (2025)

BCL2L1 induction in metastasis to the brain in humans with breast cancer.
par: Mamoor, Shahan
Publié: (2025)

The range of Xist transcriptional targets in non-small cell lung cancer: BTBD7.
par: Mamoor, Shahan
Publié: (2025)

Xist is activated during resistance in triple negative breast cancer in vitro.
par: Mamoor, Shahan
Publié: (2025)

Genes that function in axon guidance are associated with disease progression in breast and lung cancer.
par: Mamoor, Shahan
Publié: (2025)

ABCA12 functions in multi-drug resistance in human cancer.
par: Mamoor, Shahan
Publié: (2025)

Fam234b is selectively activated during the first cell division of the human embryo.
par: Mamoor, Shahan
Publié: (2026)

ABCG2 functions in multi-drug resistance in human cancer in metastasis to the bone.
par: Mamoor, Shahan
Publié: (2025)

SLX1B is active during transformation and controls relapse and resistance in human cancer.
par: Mamoor, Shahan
Publié: (2025)

ECT2 is a sensitive and specific marker of transformation in the human breast.
par: Mamoor, Shahan
Publié: (2025)

ECT2 is a sensitive and specific marker of transformation in the human breast.
par: Mamoor, Shahan
Publié: (2025)

Phosphatase targeting in Luminal B breast cancer: PGP.
par: Mamoor, Shahan
Publié: (2025)

Phosphatase targeting in Luminal B breast cancer: PNKP.
par: Mamoor, Shahan
Publié: (2025)

Kinase targeting in Luminal B breast cancer: DTYMK.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in breast cancer for the treatment of liver metastasis: AFM.
par: Mamoor, Shahan
Publié: (2025)

SSX2IP induction in basal subtype breast cancer.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in breast cancer for the treatment of liver metastasis: HHEX.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in breast cancer for the treatment of liver metastasis: BAAT.
par: Mamoor, Shahan
Publié: (2025)

Kinase targeting in Luminal B breast cancer: CDK5.
par: Mamoor, Shahan
Publié: (2025)

ABC transporter multi-drug resistance genes ("pumps") in humans with non-small cell lung cancer.
par: Mamoor, Shahan
Publié: (2025)

Feedback activation of VEGF-A resulting from PAX8 inhibition in cancer cells.
par: Mamoor, Shahan
Publié: (2026)

Therapeutic targeting in breast cancer for the treatment of metastasis to the skeletal system: SRC.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in breast cancer for the treatment of lung metastasis: ENOPH1.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in breast cancer for the treatment of metastasis to the skeletal system: SHPK.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in breast cancer for the treatment of lung metastasis: MTFP1.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in breast cancer for the treatment of lung metastasis: CDK7.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in breast cancer for the treatment of liver metastasis: MINPP1.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in breast cancer for the treatment of lung metastasis: WNK3.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in breast cancer for the treatment of lung metastasis: PANK1.
par: Mamoor, Shahan
Publié: (2025)